Navigation Links
Americans United for Life Assesses State Ballot Initiative Outcomes, Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues
Date:11/5/2008

ted measure creates financial incentives for healthcare insurance companies to deny coverage for life-saving treatment and to pressure vulnerable patients to choose physician-assisted suicide. In addition, the measure does not provide adequate safeguards for those suffering from treatable mental illnesses, and requires physicians participating in patient suicides to falsify death certificates.

"The approval of Washington Initiative 1000 poses dangers for the rest of the nation," stated J. Margaret Datiles, AUL Staff Counsel. "Now that physician-assisted suicide has been legalized in a state other than Oregon, assisted-suicide advocates will be working relentlessly to legalize the practice across the country."

Michigan: Approval of Proposal 2 (Embryonic Stem-Cell Research)

Michigan voters approved Proposal 2, the "Stem Cell Initiative." The amendment legalizes destructive research on human embryos, and will allow government funding for research on human embryos produced in fertility clinics.

"It's deeply troubling that a state would vote to legalize destructive embryonic stem-cell research at a time when research using adult stem cells is making such progress. It is truly a waste," added Smith.

South Dakota: Defeat of Initiated Measure 11 (Abortion Ban)

South Dakota failed to pass Initiated Measure 11, a constitutional amendment that would have banned abortions in South Dakota, except for those performed in cases of rape or incest, or when continued pregnancy severely endangers the woman's life or health. In 2006, South Dakota voters failed to pass a similar ban.

"Although ultimately unsuccessful, Initiated Measure 11 furthered the debate over the impact of abortion on women, the unborn, and our nation," said AUL Senior Counsel Clarke Forsythe. "Given the mounting evidence of the negative impact of abortion, this is a discussion that we must continue to pursue in the days ahead."

Colorado: Defeat of Propositio
'/>"/>

SOURCE Americans United For Life
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
5. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
6. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
7. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
8. National Council on Disability Urges Congress to Support Americans with Disabilities Act Restoration
9. Few Americans Know of Leg Artery Danger
10. More Americans Urged to Get Flu Shots
11. Pelosi: Todays Sweeping, Bipartisan Legislation to Improve Drug Safety is a Victory for All Americans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... In 2014, the FDA approved 44 drugs, with ... scoring 4 drug approvals in the USA. The infectious ... drug products, followed by oncology therapy with 18% of ... CDK inhibitors keep on attracting large-cap pharmacos. Nivolumab and ... metastatic melanoma, and at present, they are being investigated ...
(Date:3/5/2015)... 2015 AxoGen, Inc. (NASDAQ: AXGN) ... peripheral nerve repair market, reported record revenue of $4.79 ... compared to $2.98 million in the year-ago fourth quarter ... , “Our strong fourth quarter revenue growth reflects ... products which is driving increased surgeon adoption of our ...
(Date:3/5/2015)... March 05, 2015 HomeCEUConnection.com ... March with extra savings on their nutrition ... of health and nutrition, HomeCEUConnection.com is offering ... the promo code, NUTRITION2015 . , ... , HomeCEUConnection.com provides high-quality continuing education ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 TCS Healthcare ... solutions for the population health management arena, is pleased ... case management software, ACUITY Advanced Care™ (ACUITY) version 7.20. ... improved performance and the advantages of automation. , The ... ET, will be led by Jeff Frater, RN, BSN, ...
(Date:3/5/2015)... 05, 2015 University of Western ... in 1904, has launched a new center of ... changes. The Northwest Center for Lifestyle and Functional ... community outreach, and conduct research in the areas ... and nutrition. The center will target efforts on ...
Breaking Medicine News(10 mins):Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
... living only days longer despite treatment advances, study finds , ... preterm babies in England have not improved over the past ... active treatment, a new study shows. , Researchers analyzed the ... of pregnancy, which is considered to be at the "margins ...
... dismiss need for long-term antibiotic therapy, but opponents call ... News) -- After more than a year of study, ... of America has decided that controversial guidelines for the ... be changed. , The guidelines, first adopted in 2006, ...
... ... pre-event for the American Cancer Society’s highly anticipated “Starry Night Gala” that will occur ... ... 21, 2010 -- “An Evening of Hope” is the official pre-event for the ...
... ... , ... prevention and management has come a long way in the last few decades. Advent of ... evil monster., , ,We are excited though to tell about the latest technique Dr. Khanna ...
... didn,t make a difference, study finds , THURSDAY, April ... to wait longer for diagnosis and treatment than white ... finds. , Researchers from the GW Cancer Institute looked ... 1997 and 2009 at seven hospitals and clinics in ...
... Employees hold fundraiser ... ... the recovery efforts in Haiti, AthletiCo Physical and Occupational Therapy held a special jean ... from the event is being donated to Partners in Health Stand with Haiti . ...
Cached Medicine News:Health News:Youngest Preemies' Survival Rate Unchanged 2Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 2Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 3Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 4Health News:“An Evening Of Hope” - Tonight is the Official Pre-Event for this Year's American Cancer Society Starry Night Gala 2Health News:Glued graft for Pterygium Yield Better Cosmetic Results 2Health News:Glued graft for Pterygium Yield Better Cosmetic Results 3Health News:Black Women Wait Longer for Breast Cancer Diagnosis, Treatment 2Health News:AthletiCo Physical and Occupational Therapy Supports Partners in Health Stand with Haiti 2
(Date:3/5/2015)... PharmaTech (Cayman) Inc. (NYSE: WX ), a ... the pharmaceutical, biotechnology, and medical device industries, with operations ... financial results for the fourth quarter and full year ... Net Revenues Increased 21.3% Year Over Year to $190.6 ... Year Over Year to $140.5 Million , Manufacturing ...
(Date:3/5/2015)... NEW YORK , March 5, 2015 /PRNewswire/ ... evolving set of regulations, Ethics & Compliance professionals ... according to a new survey issued today by ... services and education. An overwhelming majority of respondents ... far the most important component of E&C training ...
(Date:3/5/2015)... --  ndd Medical Technologies , a leader in innovative ... technology, announced that its EasyOne Pro® was used at ... Pulmonary Fibrosis Support Group. The clinic targeted patients with ... well as those suspected of having ILD or PF. ... square inches, EasyOne Pro provides accurate respiratory test results ...
Breaking Medicine Technology:WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 2WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 3WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 6WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 7WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 8WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 9WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 10WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 11WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 12WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 13WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 14WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 15WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 16WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 17WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 18WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 19WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 20WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 21WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results 22Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3
... and Phase 1b Combination Clinical Trials ... Anti-Leukemic Activity, SOUTH SAN FRANCISCO, Calif., June 16 ... two,clinical trials of the company,s lead drug candidate, voreloxin (formerly,SNS-595), ... when,used as a single agent in relapsed or refractory patients ...
... Patients Not Optimally Controlled with, Levodopa ... Hours Per Day, RESEARCH TRIANGLE PARK, N.C., ... announced the approval of Requip(R),XL(TM) (ropinirole extended-release tablets) ... and symptoms of idiopathic Parkinson,s disease. Requip XL ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 2U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 3U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 4U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease 5
... Technologies, The UroMax Ultra ia designed ... high pressure and low profile., Refolding ... a remarkably strong material that is ... materials., Non-Compliant Balloons, A compliant balloon ...
... Fr Diameter with Two Large Working Channels; ... MICRO-6 Semi-Rigid Ureteroscope is the smallest ureteroscope ... and therapeutic procedures. The ACMI MICRO-6 Ureteroscope ... procedures with minimal or no dilation or ...
... is a self-dilating, semi-rigid autoclavable operating ureteroscope ... image bundle for an enhanced, clear image. ... to "0" diopters. The direction of view ... passage. The straight access operating channel is ...
... tip diameter of only 6.9Fr (2.3mm) ... range of 180 for and easy ... observation, a new optical system has ... (3.9mm) sheath dilator, 0.035" guidewire compatible, ...
Medicine Products: